|
|
|
| Incidence trend and age-period-cohort analysis of hepatitis B among people aged under 30 years in Quzhou City from 2005 to 2024 |
| ZHENG Canjie1, YIN Zhiying1, HE Hanqing2, ZHOU Yang2
|
1. Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang 324000, China;
2. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China |
|
|
|
|
Abstract Objective To investigate the trend in reported incidence of hepatitis B and to assess the effects of age, period, and birth cohort among people aged <30 years in Quzhou City, Zhejiang Province from 2005 to 2024. Methods Reported cases of hepatitis B among people aged <30 years in Quzhou City from 2005 to 2024 were collected from the Infectious Disease Reporting Information System of Chinese Disease Prevention and Control Information System. The reported incidence was calculated. The average annual percent change (AAPC) was used to analyze the trend in reported incidence from 2005 to 2024. An age-period-cohort model was employed to analyze the effects of age, period, and birth cohort on the reported incidence of hepatitis B. Results From 2005 to 2024, a total of 3 805 hepatitis B cases were reported among people aged <30 years in Quzhou City, with an average annual reported incidence of 31.61/105. The average annual reported incidence of hepatitis B was higher in males than in females (36.65/105 vs. 26.08/105, P<0.05). From 2005 to 2024, the reported incidence of hepatitis B among the entire people aged <30 years, as well as among males and females separately in Quzhou City, showed declining trends (AAPC=-9.887%, -10.415%, and -9.320%, respectively, all P<0.05). The age-period-cohort model analysis revealed that the incidence first decreased and then increased with age, declining from 4.21/105 in the age group of 0-<5 years to 2.07/105 in the age group of 10-<15 years, before rising to 22.49/105 in the age group of 25-<30 years. Using the 2010-2014 period as the reference, the risk of hepatitis B showed a decreasing trend over time. The RR value decreased from 1.842 (95%CI: 1.433-2.366) for 2005-2009 to 0.446 (95%CI: 0.294-0.675) for 2020-2024. Using the 2000-2004 birth cohort as the reference, the risk showed a decreasing trend with more recent birth years. The highest risk was observed in the 1980-1984 birth cohort, with an RR value of 4.731 (95%CI: 3.083-7.259). The age, period, and cohort effects on the reported incidence of hepatitis B among males and females were generally consistent with those observed in the entire population. Conclusions From 2005 to 2024, the reported incidence of hepatitis B among people aged <30 years in Quzhou City showed a declining trend, while exhibiting a pattern of first decreasing and then increasing with age. Furthermore, the risk of hepatitis B incidence demonstrated a decreasing trend over both time periods and birth cohorts.
|
|
Received: 20 August 2025
Revised: 17 November 2025
Published: 25 December 2025
|
|
|
|
|
|
[1] 周天天,张丹,王锐泽,等.2020年陕西省1~69岁人群乙型肝炎血清流行病学调查[J].中国疫苗和免疫,2023,29(2):164-168.
ZHOU T T,ZHANG D,WANG R Z,et al.A hepatitis B sero-epidemiological survey among 1-69-year-olds in Shaanxi Province, 2020[J].Chin J Vaccines Immun,2023,29(2):164-168.(in Chinese)
[2] CAO G Y,LIU J,LIU M.Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019:findings from the Global Burden of Disease Study[J].Chin Med J,2022,135(17):2049-2055.
[3] World Health Organization.Hepatitis B[EB/OL].[2025-11-17] .https://www.who.int/zh/news-room/fact-sheets/detail/Hepatitis-b.
[4] ZHENG H,WANG Y,WANG F Z,et al.New progress in HBV control and the cascade of health care for people living with HBV in China:evidence from the fourth national serological survey,2020[J/OL].Lancet Reg Health West Pac,2024,51[2025-11-17] .https://doi.org/10.1016/j.lanwpc.2024.101193.
[5] ZHANG J Y,LU Y B,LI H R,et al.Lip and oral cavity cancer burden and related risk factors in China:estimates and forecasts from1990 to 2049[J/OL].Healthcare (Basel),2022,10[2025-11-17] .https://doi.org/10.3390/healthcare10091611.
[6] ROSENBERG P S,CHECK D P,ANDERSON W F.A web tool for age-period-cohort analysis of cancer incidence and mortality rates[J].Cancer Epidemiol Biomarkers Prev,2014,23(11):2296-2302.
[7] 黄勇,王雯,张春焕,等.2005—2018年广州市乙型肝炎流行病学特征分析[J].疾病监测,2020,35(12):1120-1124.
HUANG Y,WANG W,ZHANG C H,et al.Epidemiological characteristics of hepatitis B in Guangzhou,2005-2018[J].Dis Surveill,2020,35(12):1120-1124.(in Chinese)
[8] 徐旭卿,林霞,曾蓓蓓,等.1991—2007年浙江省乙型病毒性肝炎报告发病特征分析[J].疾病监测,2010,25(4):263-266.
XU X Q,LIN X,ZENG B B,et al.Epidemiological analysis of viral hepatitis B in Zhejiang,1991-2007[J].Dis Surveill,2010,25(4):263-266.(in Chinese)
[9] 李傅冬,何凡,何寒清,等.2004—2020年浙江省10岁以下儿童乙型病毒性肝炎发病的年龄-时期-队列分析[J].预防医学,2024,36(9):737-740.
LI F D,HE F,HE H Q,et al.Age-period-cohort analysis of the incidence of hepatitis B among children aged under 10 years in Zhejiang Province from 2004 to 2020[J].China Prev Med J,2024,36(9):737-740.(in Chinese)
[10] FANG K,SHI Y Y,ZHAO Z Y,et al.Trends in disease burden of hepatitis B infection in Jiangsu Province,China,1990-2021[J].Infect Dis Model,2023,8(3):832-841.
[11] 万咏梅,王富珍,张国民,等.成人乙型肝炎感染风险和疾病负担[J].中国疫苗和免疫,2019,25(5):611-616.
WAN Y M,WANG F Z,ZHANG G M,et al.Risk and disease burden of adult hepatitis B infection[J].Chin J Vaccines Immun,2019,25(5):611-616.(in Chinese)
[12] 王富珍,郑徽,孙校金,等.中国控制乙型病毒性肝炎的成就与展望[J].中国疫苗和免疫,2019,25(5):487-492.
WANG F Z,ZHENG H,SUN X J,et al.Achievements and prospects for hepatitis B prevention and control in China[J].Chin J Vaccines Immun,2019,25(5):487-492.(in Chinese)
[13] 国家卫生健康委员会.国家免疫规划疫苗儿童免疫程序及说明(2021年版)[J].中国病毒病杂志,2021,11(4):241-245.
National Health Commission of the People's Republic of China.Program and description of national immunization program vaccine for children(2021 edition)[J].Chin J Viral Dis,2021,11(4):241-245.(in Chinese) |
|
|
|
